HARNESSING THE POWER OF BIOINFORMATICS IN DRUG DISCOVERY AND DEVELOPMENT
Keywords:
Bioinformatics, Drug Discovery, Drug Development, Molecular DockingAbstract
Bioinformatics has revolutionized drug discovery and development by providing computational tools that enable the analysis and interpretation of vast biological data. This multidisciplinary field integrates biology, computer science, and information technology to enhance drug design, identification of therapeutic targets, and prediction of drug efficacy. In drug discovery, bioinformatics tools such as molecular docking, virtual screening, genomics, and proteomics are used to identify new drug candidates, optimize lead compounds, and predict drug interactions. This article explores the role of bioinformatics in each stage of drug discovery, from target identification and screening to the design and clinical development of therapeutic agents. Emphasizing the integration of big data and artificial intelligence, it further investigates how these technologies are transforming traditional drug discovery paradigms. The challenges, future directions, and applications of bioinformatics in personalized medicine and drug resistance are also discussed.
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles published in The Nature are licensed under an open access policy, allowing free and unrestricted access to the content. Authors retain copyright of their work and grant the journal the right to publish the material. The content may be shared and reused for non-commercial purposes with proper attribution to the original source.
